ANESTHETIC MANAGEMENT AND INTENSIVE CARE IN THE PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH LEFT HEART DISEASES
https://doi.org/10.21292/2078-5658-2019-16-3-33-40
Abstract
Nowadays, the term "pulmonary hypertension" (PH) means a pathophysiological condition that may involve multiple clinical conditions and complicate the majority of cardiovascular and respiratory diseases. Clinical classification identifies 5 groups of pulmonary hypertension. This review focuses on group 2 - pulmonary hypertension due to left heart disease (PH due to LHD). In the general structure it takes about 80%. In routine practice, the contribution of this pathology to main disease is often underestimated, which can lead to increased mortality. The purpose of the literature review is to systematize and provide anesthesiologists with information on modern approaches to the diagnosis and treatment of PH due to LHD. The review presents data of the epidemiology and pathogenesis of this condition, describes the key concepts of adequate anesthetic management and effective intensive treatment of pulmonary hypertension in patients with left heart diseases.
About the Authors
A. E. BAUTIN
Almazov National Medical Research Center
Russian Federation
Russian Federation
Andrey E. Bautin Doctor of Medical Sciences, Associate Professor, Head of Anesthesiology and Intensive Care Research Laboratory, Professor of Anesthesiology and Intensive Care Department.
15, Parkhomenko Ave., St. Petersburg, 194156
A. V. KSENDIKOVA
Almazov National Medical Research Center
Russian Federation
Anastasia V. KsendikovaAnesthesiologist and Emergency Physician of Anesthesiologyand Intensive Care Department with Intensive Care Wards no. 2for Cardiac Surgery.15, Parkhomenko Ave., St. Petersburg, 194156
Russian Federation
Anastasia V. KsendikovaAnesthesiologist and Emergency Physician of Anesthesiologyand Intensive Care Department with Intensive Care Wards no. 2for Cardiac Surgery.15, Parkhomenko Ave., St. Petersburg, 194156
A. S. YAKOVLEV
Almazov National Medical Research Center
Russian Federation
Andrey S. YakovlevHead of Anesthesiology and Intensive Care Departmentwith LKR Intensive Care Wards no. 1.15, Parkhomenko Ave., St. Petersburg, 194156
Russian Federation
Andrey S. YakovlevHead of Anesthesiology and Intensive Care Departmentwith LKR Intensive Care Wards no. 1.15, Parkhomenko Ave., St. Petersburg, 194156
A. O. MARICHEV
Almazov National Medical Research Center
Russian Federation
Aleksandr O. MarichevHead of Anesthesiology and Intensive Care Departmentwith Intensive Care Wards no. 7 for Cardiac Surgery,Assistant of Anesthesiology and IntensiveCare Department.15, Parkhomenko Ave., St. Petersburg, 194156
Russian Federation
Aleksandr O. MarichevHead of Anesthesiology and Intensive Care Departmentwith Intensive Care Wards no. 7 for Cardiac Surgery,Assistant of Anesthesiology and IntensiveCare Department.15, Parkhomenko Ave., St. Petersburg, 194156
N. R. ABUTALIMOVA
Almazov National Medical Research Center
Russian Federation
Napisat R. AbutalimovaResident of Anesthesiology and IntensiveCare Department.15, Parkhomenko Ave., St. Petersburg, 194156
Russian Federation
Napisat R. AbutalimovaResident of Anesthesiology and IntensiveCare Department.15, Parkhomenko Ave., St. Petersburg, 194156
L. I. KARPOVA
Almazov National Medical Research Center
Russian Federation
Lyudmila I. KarpovaAnesthesiologist and Emergency Physician of Anesthesiologyand Intensive Care Department with Intensive Care Wards no. 7for Cardiac Surgery15, Parkhomenko Ave., St. Petersburg, 194156
Russian Federation
Lyudmila I. KarpovaAnesthesiologist and Emergency Physician of Anesthesiologyand Intensive Care Department with Intensive Care Wards no. 7for Cardiac Surgery15, Parkhomenko Ave., St. Petersburg, 194156
A. M. RADOVSKY
Almazov National Medical Research Center
Russian Federation
Aleksey M. RadovskyAnesthesiologist and Emergency Physician of Anesthesiologyand Intensive Care Department with Intensive Care Wards no. 7for Cardiac Surgery15, Parkhomenko Ave., St. Petersburg, 194156
Russian Federation
Aleksey M. RadovskyAnesthesiologist and Emergency Physician of Anesthesiologyand Intensive Care Department with Intensive Care Wards no. 7for Cardiac Surgery15, Parkhomenko Ave., St. Petersburg, 194156
V. V. OSOVSKIKH
Almazov National Medical Research Center
Russian Federation
Viktor V. OsovskikhCandidate of Medical Sciences, Associate Professorof Anesthesiology and Intensive Care Department.15, Parkhomenko Ave., St. Petersburg, 194156
Russian Federation
Viktor V. OsovskikhCandidate of Medical Sciences, Associate Professorof Anesthesiology and Intensive Care Department.15, Parkhomenko Ave., St. Petersburg, 194156
References
1. Bautin А.E., Yakovlev А.S., Zayashnikov S.V. et al. Comparison of hemodynamic effects of inhaled iloprost and nitric oxide when prescribed to patients with pronounced left ventricular systolic dysfunction. Rossiysky Kardiologicheskiy Journal, 2017, no. 12, pp. 97-103. (In Russ.)
2. Zabolotskikh I.B., Bautin А.E., Bayalieva А.Zh. et al. Perioperatsionnoe vedenie patsientov s soputstvuyuschey patologiey klapannogo apparata serdtsa. Klinicheskie rekomendatsii. [Peri-operative management of patients with concurrent cardiac valve disorders. Clinical recommendations]. Obscherossiyskaya Obschestvennaya Organizatsiya Federatsiya Anesteziologov i Reanimatologov Publ., 2018, Epub., Available: http://far.org.ru/recomendation
3. Bacal F., de Freitas A.F., Moreira L.F. et al. Validation of a cutoff value on echo Doppler analysis to replace right heart catheterization during pulmonary hypertension evaluation in heart transplant candidates. Transplant. Proc., 2010, vol. 42, pp. 535-538.
4. Berthelot E., Bauer F., Eicher J.C. et al. Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues. ESC Heart Failure, 2018, vol. 5, pp. 755-763.
5. Callahan W.E., Amorosino C.S. Endothelial dysfunction in pulmonary hypertension. N. Engl. J. Med., 1992, vol. 327, pp. 117-119.
6. Fleisher L.A., Fleischmann K.E., Auerbach A.D. et al. ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of cardiology. J. Am. Coll. Cardiol., 2014, vol. 64, pp. 77-137.
7. Fonarow G.C. The treatment targets in acute decompensated heart failure. Rev. Cardiovasc. Med., 2001, vol. 2, pp. 7-12.
8. Galiè N., Humbert M., Vachiery J.L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur. Heart J., 2016, vol. 37, pp. 67-119.
9. Ghio S., Gavazzi A., Campana C. et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. JACC, 2001, vol. 37, pp. 183-188.
10. Guazzi M., Galie N. Pulmonary hypertension in left heart disease. Eur. Respir. Rev., 2012, vol. 21, pp. 338-346.
11. Kjaergaard J., Akkan D., Iversen K.K. et al. Prognostic importance of pulmonary hypertension in patients with heart failure. Am. J. Cardiol., 2007, vol. 99, pp. 1146-1150.
12. Kristensen S.D., Knuuti J., Saraste A. et al. ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur. Heart J., 2014, vol. 14, pp. 2383-2431.
13. Landoni G., Fochi O., Bignami E. et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A metaanalysis of randomized controlled studies on clinically relevant endpoints. HSR Proc. Intens. Care Cardiovasc. Anesth., 2009, vol. 1, pp. 34-43.
14. Lestar M., Gunnarsson L., Lagerstrand L. et. al. Hemodynamic perturbations during robot-assisted laparoscopic radical prostatectomyin 458 Trendelenburg position. Anesth. Analg., 2011, vol. 113, pp. 1069-1075.
15. Miller W., Grill D., Borlaug B. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC: Heart Failure, 2013, vol. 1, pp. 290-299.
16. Morrell N., Adnot S., Archer S. et al. Cellular and molecular basis of pulmonary arterial hypertension. J. Am. Coll. Cardiol., 2009, vol. 54, pp. 20-31.
17. Ponikowski P., Voors A.A., Anker S.D. et. al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail., 2016, vol. 18, pp. 891-975.
18. Popescu W.M., Bell R., Duffy A.J. et. al. A pilot study of patients with clinically severe obesity undergoing laparoscopic surgery: evidence for impaired cardiac performance. J. Cardiothorac. Vasc. Anesth., 2011, vol. 25, pp. 943-949.
19. Vahanian A., Alfieri O., Andreotti F. et. al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J., 2012, vol. 33, pp. 2451-2496.
Review
For citations:
BAUTIN A.E., KSENDIKOVA A.V., YAKOVLEV A.S., MARICHEV A.O., ABUTALIMOVA N.R., KARPOVA L.I., RADOVSKY A.M., OSOVSKIKH V.V. ANESTHETIC MANAGEMENT AND INTENSIVE CARE IN THE PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH LEFT HEART DISEASES. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2019;16(3):33-40. (In Russ.) https://doi.org/10.21292/2078-5658-2019-16-3-33-40
Email this article 